Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
about
Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
@en
type
label
Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
@en
prefLabel
Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
@en
P17
P6153
P1050
P131
P1476
A Phase 2 Study Of Inotuzumab ...... otherapy Or Radioimmunotherapy
@en
P3098
NCT00868608
P580
2009-07-30T00:00:00Z
P582
2012-01-10T00:00:00Z